| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |